[Bio-Medical/Healthcare]
DiaVision
-
Desired form of investment :
VC investment(series-A)
-
Year of establishment : 2021
-
A digital healthcare service platform company utilizing image analysis technology
- Mobile side-flow analysis
- Home healthcare platform for hormone and metabolic disease prevention
- Building a data pool for the development of digital therapeutics through big data mining
CEO: Lee Soo Kyung
Number of employees : 6
Key Technology : AI
Reason to Invest(Our Product & Service)
- Product name : Smart Vision
- Core technologies : Covid-19 ag test analysis app (Imaging processing tech, AI tech)/Hormones, Infectious disease app(AI tech, Personalize Analysis tech)
- Performance indicators : Showing over 98% of detection ratio evaluated by 2 major medical centers.
Our Achievement
2022. 02 : Attracted CVC (SVIC) Investment
2022. 04 : Participated in the GOvernment incubating Program
2022. 05 : Attracted CVC Lotte ventures Investment
Inquiry
Want more information about this company? Leave a message and we will contact you.
We recognize the importance of privacy and confidentiality of personal information.
We protect and use personal information about you in limited scope by
Korea Personal Information Act and our
Privacy Policy.
If you have read and agreed to our privacy policy, check the boxes and
click "Send" button.